Materials And Products Tenders

Open House Original Discount Contracts 2025-10 - Umeclidinium Bromide+Vilanterol

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by an Open House Model to the Active Ingredient Ticagrelor (Atc Code According to Who: B01ac24)

Pharmaceutical Discount Contracts with Accession Option

Open House Medicinal Practice Treaties for the Active Ingredient Ublituximab, Atc L04ag14

Completion not Excl. Pharmaceutical Discount Club. According to § 130A Para. 8 Sgb V by Means of an Open House Model to the Active Ingredient Sunatinib (Atc Code According to Who: L01ex01)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by an Open House Model to the Active Ingredient Icatibant (Atc Code According to Who: B06ac02)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by an Open House Model to the Active Ingredient Cinnaricine/Dimenhydrinate (Atc Code According to Who: N07ca52; Official Atc: N07ca22)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Infliximab (Atc Code According to Who: L04ab02)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Fondaparinux (Atc Code According to Who: B01ax05)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by an Open-House Model to the Active Ingredient Tamsulosin/Dutasteride (Atc Code According to Who: G04ca52)